Stockscreener 앱 받기
69.77
0.29%
0.20
시간 외 거래:
69.77
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Will Soleno Therapeutics Inc. benefit from macro trends2025 Volatility Report & Community Shared Stock Ideas - Newser
Will Soleno Therapeutics Inc. continue its uptrendJuly 2025 Reactions & Daily Profit Focused Stock Screening - Newser
Soleno Therapeutics Inc. stock trend forecastTrade Performance Summary & AI Driven Stock Reports - Newser
Soleno Therapeutics Inc. stock trendline breakdown2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
Ranking Soleno Therapeutics Inc. among high performing stocks via toolsTrade Risk Report & Long-Term Safe Investment Plans - Newser
Analyzing Soleno Therapeutics Inc. with multi timeframe chartsSell Signal & Verified Short-Term Trading Plans - Newser
ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - GlobeNewswire Inc.
Published on: 2025-09-06 01:23:59 - خودرو بانک
CEO Moves: What is Soleno Therapeutics Inc.’s market positionWeekly Market Outlook & Daily Technical Forecast Reports - خودرو بانک
What is the long term forecast for Soleno Therapeutics Inc. stockJuly 2025 Trade Ideas & High Accuracy Swing Entry Alerts - خودرو بانک
Does Soleno Therapeutics Inc. have declining or rising EPSJuly 2025 Decliners & Comprehensive Market Scan Insights - خودرو بانک
Is Soleno Therapeutics Inc. a momentum stockJuly 2025 Review & Free Technical Confirmation Trade Alerts - خودرو بانک
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - The Malaysian Reserve
Regulatory and Legal Risks in Biotech Investing: Lessons from Soleno Therapeutics (SLNO) - AInvest
Can Soleno Therapeutics Inc. sustain its profitabilityJuly 2025 Earnings & Real-Time Buy Signal Alerts - خودرو بانک
News impact scoring models applied to Soleno Therapeutics Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire
Understanding Soleno Therapeutics Inc.’s price movement2025 Retail Activity & Safe Entry Zone Identification - Newser
Best data tools to analyze Soleno Therapeutics Inc. stockWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Using fundamentals and technicals on Soleno Therapeutics Inc.Weekly Profit Analysis & Low Risk Entry Point Guides - Newser
Is Soleno Therapeutics Inc. showing signs of accumulationJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Analyzing drawdowns of Soleno Therapeutics Inc. with statistical toolsJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
Soleno Therapeutics: A High-Stakes Play in Rare Diseases with Metabolic Potential - AInvest
Transcript : Soleno Therapeutics, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 01 - MarketScreener
Published on: 2025-09-05 00:04:12 - Newser
understanding soleno therapeutics inc.’s price movementJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - Newser
What are the risks of holding Soleno Therapeutics Inc.Trade Performance Summary & AI Driven Price Forecasts - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating Fortinet, - GlobeNewswire
Soleno Therapeutics' Strategic Position in the 2025 Healthcare Innovation Landscape: A Deep Dive into Pipeline Differentiation and Market Readiness - AInvest
Soleno Therapeutics: Navigating the Diabetes Therapeutics Landscape Through PWS-Centric Innovation - AInvest
Advanced analytics toolkit walkthrough for Soleno Therapeutics Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Why Soleno Therapeutics Inc. stock is on top investor watchlistsQuarterly Earnings Summary & Weekly Momentum Stock Picks - Newser
How cyclical is Soleno Therapeutics Inc.’s revenue streamEarnings Recap Summary & Free Safe Capital Growth Stock Tips - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is it too late to sell Soleno Therapeutics Inc.Portfolio Update Report & Verified Momentum Stock Alerts - Newser
Is Soleno Therapeutics Inc. stock bottoming outQuarterly Profit Review & Step-by-Step Swing Trade Plans - Newser
What institutional flow reveals about Soleno Therapeutics Inc.July 2025 Recap & Daily Price Action Insights - Newser
Soleno Therapeutics, Inc. $SLNO Shares Bought by Northern Trust Corp - Defense World
Is Soleno Therapeutics Inc. a good stock for dollar cost averaging2025 Year in Review & Low Drawdown Trading Strategies - خودرو بانک
Published on: 2025-09-03 01:49:16 - Newser
Regression analysis insights on Soleno Therapeutics Inc. performance2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
What is the next catalyst for Soleno Therapeutics Inc.July 2025 Decliners & AI Forecast Swing Trade Picks - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):